Background: The aim of the present study was to establish whether polymorphisms, especially those within the promoter region, of the β 2 -adrenoceptor gene (ADRB2) influence β 2 -adrenoceptor expression in human lung.
Methods:The density of β-adrenoceptors in human lung tissue (n=88) was determined by saturation binding using the radioligand, iodinated cyanopindolol. Discrimination of β 1 -and β 2 -adrenoceptors was determined using the highly selective β 1 -adrenoceptor antagonist, CGP20712A. Genotype was determined at 5 positions of ADRB2 previously reported as polymorphic. Potential influences of single nucleotide polymorphisms (SNPs) within the promoter region (-367, -47) and coding block (46, 79, 491) of ADRB2 on β 2 -adrenoceptor expression were investigated.
Results:The density of β 2 -adrenoceptors was variable among the 88 lung preparations studied ranging from 17 to 177 fmol/mg protein (mean±S.E.M., 72±4 fmol/mg protein).There was no influence of genotype on β 2 -adrenoceptor expression for any of the polymorphisms studied except at position 491. The polymorphism at position 491C>T, leading to a change from thr to ile at amino acid 164, is uncommon. Preparations genotyped as heterozygous (126±15 fmol/mg protein; n=5) expressed significantly (P = 0.0005) higher levels of β 2 -adrenoceptor than those that were homozygous (69±4 fmol/mg protein; n=83).
M A N U S C R I P T A C C E P T E D ARTICLE IN PRESS